Completed PHASE3 INTERVENTIONAL 2-arm NCT01798381

Essential Fatty Acids in Adult ADHD (OCEAN-GER)

The Relationship of Essential Fatty Acids to Cognitive, Electrophysiological and Behavioural Function in Adults With Attention Deficit Hyperactivity Disorder and Controls

Sponsor: Universität des Saarlandes

Conditions Adult Attention Deficit Hyperactivity Disorder

Interventions Essential fatty acids

Updated 7 times since 2017 Last updated: Oct 27, 2020 Started: Dec 31, 2012 Primary completion: Dec 31, 2014 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Adult Attention Deficit Hyperactivity Disorder, this trial is completed. The trial is conducted by Universität des Saarlandes and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Feb 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Feb 2021 [monthly]

Completed PHASE3
Nov 2020 — Jan 2021 [monthly]

Completed PHASE3

Status: Unknown Status → Completed

▶ Show 2 earlier versions

Jun 2018 — Nov 2020 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universität des Saarlandes

Data source: Universität des Saarlandes

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Homburg/Saar, Germany